PG011
/ PersonGen Biomedicine
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
September 10, 2026
A Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis
(clinicaltrials.gov)
- P2 | N=179 | Completed | Sponsor: Prime Gene Therapeutics Co., Ltd. | Active, not recruiting ➔ Completed
Trial completion • Allergic Rhinitis • Immunology • Inflammation
October 31, 2025
Mass Balance Study of PG-011 in Chinese Healthy Adult Male Participants
(ChiCTR)
- P1 | N=10 | Not yet recruiting | Sponsor: Beijing GoBroad Hospital; Prime Gene Therapeutics Co., Ltd.
New P1 trial • Allergic Rhinitis • Immunology • Inflammation
1 to 2
Of
2
Go to page
1